Type:
Presentación Electrónica Educativa
Keywords:
Metastases, Inflammation, Treatment effects, CT, MR, Oncology, Liver
Authors:
I. Puig Povedano1, E. Andía Navarro1, E. M. Merino Serra1, D. Martinez de la Haza1, A. Sánchez Márquez1, L. Martinez Carnicero2; 1Hospitalet De Llobregat/ES, 2L'Hospitalet de Llobregat/ES
DOI:
10.1594/seram2014/S-1305
Bibliografía
1.Kulemann V,
Schima W,
Tamandl D.
Preoperative detection of colorectal liver metastasis in fatty liver.
MDCT or MRI.
EJR 79-2011.
2.Sica,
G.T.,
Ji Hoon,
Ros,
Pablo R.
CT and MRI of hepatic metastasis.
AJR;174:691-98.
3. Danet,I.M.,
Semelka R.,
Leonardou,P.
Spectrum of MRI Appearences of Untreated Metastases of the Liver.
AJR 2003;181:809-817.
4.Taouli,
B.,
Koh D.
Diffussion Weghted MRI of the liver.
Radiology 2010;254:47-66.
5.Luna A.,
Vilanova J.C Bases,
conceptos técnicos y aplicaciones clínicas de la RM Difusión.
aActualizaciones SERAM 2014.
6.González-Guindalini F.,
Botelho M.,
Harmath C.
Assessment of liver tumor response to therapy: Role of quantitative imaging.
Radiographics 2013;33:1781-1800.
7.Holler S.A.,
krajewsky K,
Thorton E.
Decade of molecular targeted therapy: Abdominal manifestations of drug toxicities.
What radiologists should know.
AJR 2012;199:58-64.
8.AbramsonR,
Abramson V,
Chan E.
Complications of drug targeted therapies for solid malignancies: Manifestations and mechanisms.
AJR 2013;200:475-483.